Search Results

The Aqua Medical RF Vapor System is indicated for use in the coagulation of bleeding and non-bleeding sites in the gastrointestinal tract including but not limited to the esophagus. Indications include Esophageal Ulcers, Mallory-Weiss tears, Arteriovenous Malformations, Angiomata, Barrett's Esophagus, Dieulafoy Lesions, Angiodysplasia, Gastric Antral Vascular Ectasia (GAVE) and Radiation Proctitis (RP). The device is to be used in adults only.

The Aqua RF Vapor System uses a catheter to deliver heated water vapor to the tissue surface undergoing treatment. The Aqua RF Vapor System is a catheter-based system for heating and coagulating tissue. The heat is delivered to the target tissue in the form of water vapor that is generated within the catheter tip using RF (radiofrequency) energy. Application of heat to the tissue results in coagulation of the tissues being treated. This technique avoids the need for direct RF energy application to heat the tissue. The Aqua Medical RF Vapor System consists of the following components:

• Aqua RF Vapor Generator: A software-controlled RF generator is operated through a graphical user interface (GUI) and incorporates a syringe pump that delivers saline to the catheter. Delivery of bipolar RF energy to the catheter is controlled either by an accessory foot pedal or a button incorporated in the disposable catheter.
• Aqua RF Vapor Catheters: disposable, sterile, single-use catheters with a diameter of 7 F (2.3 mm) and a length of 145 cm. There are 3 types of RF Vapor catheters available.
• Saline Delivery Tubing and Syringe: Tubing and syringe (60cc) provide a means of delivering saline to the catheter during treatment.

The provided text is a 510(k) summary for the Aqua Medical RF Vapor System, which describes modifications to an already cleared device. It does not contain information about acceptance criteria, device performance metrics, or study details such as sample size, data provenance, ground truth establishment, or expert qualifications. The document primarily focuses on demonstrating substantial equivalence to a predicate device, based on identical intended use and technological modifications (new catheter designs) that do not raise new questions of safety or effectiveness.

Therefore, I cannot provide the requested information. The text does not include:

1. A table of acceptance criteria and reported device performance.
2. Sample sizes for a test set or training set, or data provenance.
3. Number and qualifications of experts for ground truth establishment.
4. Adjudication methods.
5. Multi-reader multi-case (MRMC) comparative effectiveness study.
6. Standalone algorithm performance.
7. Type of ground truth used (pathology, outcomes data, expert consensus, etc.).
8. How ground truth for a training set was established.

The document mentions "Hardware Verification Testing," "Simulated tissue model," "Biocompatibility Testing," and "Sterilization Validation" as performance data conducted to support the modifications, but it does not detail their methods, results, or acceptance criteria in the context of device performance metrics.

Ask a specific question about this device